Organon announced a strategic investment in Claria Medical, a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy. The agreement also grants Organon the option to acquire Claria Medical.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OGN:
